Abstract
Aggressive fibromatosis is a rare neoplasm arising from musculoaponeurotic structures. Our aim is to share our experience with this rare tumor in our institute and to discuss the more perplexing recurrence patterns and the management options. This is a retrospective study of the disease, treated in our institute for the past fourteen years. A total of 36 patients were analyzed. The demographic pattern of the disease, various treatment modalities offered and their outcome along with patterns of recurrence were studied. Our study showed a demographic pattern mostly similar to the rest of the world. But the pattern of recurrence and the multicentric and the non-random pattern of presentation observed in our study showed some difference from the other studies. We suggest surgery as the primary modality with radiation reserved for select patients with margin positivity, inoperable tumors, and multiple tumors. Since the disease has a long natural history a wait and watch policy can be observed for giving adjuvant RT. There is need for prospective multi-institutional RCTs to shed light on the unknown facts about this disease.
Similar content being viewed by others
References
Alman BA, Pajerski ME, Diaz-Cano S, Corboy K, Wolfe HJ (1997) Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol 6:98–101
Wara WM, Phillips TL, Hill DR et al (1977) Desmoid tumors—treatment and prognosis. Radiology 124:225–226
Li M, Cordon-Cardo C, Gerald WL, Rosai J (1996) Desmoid fibromatosis is a clonal process. Hum Pathol 27:939–943
Merchant NP, Lewis JJ, Leung DH, Woodruff JM, Brennan MF (2012) Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer
Wold LE, Weiland LH (1983) Tumefactive fibro-inflammatory lesions of the head and neck. Am J Surg Pathol 7:477–482
Posner MC, Shiu MH, Newsome JL, Hajdu SI, Gaynor JJ, Brennan MF (1989) The desmoid tumor: not a benign disease. Arch Surg 124:191–196
Goy BW, Lee SP, Fu YS, Selch MT, Eilber F (1998) Treatment results of unresected or partially resected desmoid tumors. Am J Clin Oncol 21(6):584–590
Spear MA, Jennings LC, Mankin HJ, Spiro IJ, Springfield DS, Gebhardt MC, Rosenberg AE, Efird JT, Suit HD (1998) management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 40(3):637–645
Suit HD, Spiro IJ, Spear M (1997) Benign and low-grade tumors of the soft tissues: role for radiation therapy. Cancer Treat Res 91:95–105
Abeloff M, ArmiTAGE. J, Niederhuber. J Abeloff’s Clinical Oncology, 4th edition, May-2008
Fong Y, Rosen PP, Brennan MF (1993) Multifocal desmoids. Surgery 114:902–906
Easter DW, Halasz NA (1989) Recent trends in the management of desmoids tumors. Summary of 19 cases and review of the literature. Ann Surg 210:765–769
Leibel SA, Wara WM, Hill DR et al (1983) Desmoid tumors: local control and patterns of relapse following radiation therapy. Int J Radiat Oncol Biol Phys 9:1167–1171
Sherman NE, Romsdahl M, Evans H, Zagars G, Oswald MJ (1990) Desmoid tumors: a 20-year radiotherapy experience. Int J Radiat Oncol Biol Phys 19:37–40
Kinzbrunner B, Ritter S, Domingo J, Rosenthal CJ (1983) Remission of rapidly growing desmoid tumors after tamoxifen therapy. Cancer 52:2201–2204
Waddell WR, Gerner RE, Reich MP (1983) Nonsteroid anti-inflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomach. J Surg Oncol 22:197–211
Wilcken N, Tattersall MH (1991) Endocrine therapy for desmoid tumors. Cancer 68:1384–1388
Gronchi A, Casali PG, Mariani L (2003) Quality of surgery and outcome in extra-abdominal aggressive Fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol 21(7):1390–1397
Author information
Authors and Affiliations
Corresponding author
Additional information
Synopsis: We suggest surgery as the primary modality with radiation reserved for select patients
Rights and permissions
About this article
Cite this article
Ramamurthy, R., Arumugam, B. & Ramanandham, B. Recurrence Patterns and Management Options in Aggressive Fibromatosis. Indian J Surg Oncol 3, 222–227 (2012). https://doi.org/10.1007/s13193-012-0146-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-012-0146-2